πŸ‡ΊπŸ‡Έ FDA
Patent

US 12285460

Pharmaceutical compositions

granted A61KA61K38/08A61K38/12

Quick answer

US patent 12285460 (Pharmaceutical compositions) held by RHYTHM PHARMACEUTICALS, INC. expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RHYTHM PHARMACEUTICALS, INC.
Grant date
Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/08, A61K38/12, A61K45/06, A61K47/10